Though MYB mutational activation is known to occur in the majority of ACC (Persson et al., 2012), little else is known about the downstream consequences of MYB activation and other molecular factors involved in the initiation and progression of ACC due to a lack of stable cell cultures. This evidence concerns the gene MYB and adrenal cortex carcinoma.